Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion type Assertion NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_head.
- NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion description "[However, the prevalence of CDKN2 mutations in primary bladder tumors has been controversial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_provenance.
- NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion evidence source_evidence_literature NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_provenance.
- NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion SIO_000772 9171998 NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_provenance.
- NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion wasDerivedFrom befree-20150227 NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_provenance.
- NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_assertion wasGeneratedBy ECO_0000203 NP304240.RAF8YE8QV6T8EOdW7bynNZqbwDl21z7Dm-vk83i7WFmV4130_provenance.